5L
NVS icon

55I LLC’s Novartis NVS Stock Holding History

55I LLC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,168
Closed -$300K – 186
2019
Q4 		$300K Buy
3,168
+151
+5% +$13.5K 0.13% 112
2019
Q3 		$262K Hold
3,017
– – 0.13% 108
2019
Q2 		$275K Sell
3,017
-350
-10% -$29.6K 0.15% 93
2019
Q1 		$290K Hold
3,367
– – 0.23% 64
2018
Q4 		$259K Buy
+3,367
New +$262K 0.26% 46

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

55I LLC's NVS Position: Q1 2020 in Review

55I LLC sold out of Novartis (NVS) in Q1 2020, closing a stake of 3,168 shares — an estimated $300K sold.

55I LLC first reported a position in NVS in Q4 2018 and held it in 5 quarters. The position peaked at $300K in Q4 2019. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • 55I LLC reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • 55I LLC sold 3,168 Novartis shares in Q1 2020, an estimated $300K.
  • 55I LLC first reported a position in Novartis in Q4 2018 and held it in 5 quarters.
  • 55I LLC's Novartis position peaked at $300K in Q4 2019.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on 55I LLC's 13F filing for Q1 2020, filed 1 May 2020.